CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform. Issues related to Treasury regulations on Section 385.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148) and the Food and Drug Administration Safety and Innovation Act (P.L.112-144). H.R.512, DISARM Act of 2015. H.R.6, 21st Century Cures Act. Issues related to health care, the Food and Drug Administration (FDA), 340B Program, animal health, Senate HELP Innovation Project and oncology coverage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Budget/Appropriations BUD
H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S.3040/House Committee Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; reimbursement issues; vial size issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; Tricare formulary issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Homeland Security HOM
S.456, Cyber Threat Sharing Act of 2015, S.177/H.R.1770, Data Security and Breach Notification Act of 2015, S.1027, Data Breach Notification and Punishing Cyber Criminals Act of 2015, S.961/H.R.2205, Data Security Act of 2015; data security and cybersecurity issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Trade (domestic/foreign) TRD
Issues related to the Trans-Pacific Partnership (TPP).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.